Anaphylaxis to insect sting associated with urticaria pigmentosa

Allergy and Asthma Proceedings

Volumn 24, Issue 3, 2003, Pages 175-178

  Kim, Daniel C ^a   Horan, Richard ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; VENOM;

ANAPHYLAXIS; ARTICLE; DISEASE ASSOCIATION; EVALUATION; HUMAN; IMMUNOTHERAPY; INSECT STING; MASTOCYTOSIS; RISK FACTOR; SKIN MANIFESTATION; SKIN TEST; SYMPTOM; URTICARIA PIGMENTOSA;

ANAPHYLAXIS; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; INSECT BITES AND STINGS; MALE; MASTOCYTOSIS; MIDDLE AGED; SKIN TESTS; URTICARIA PIGMENTOSA;

EID: 0042921337     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Golkar L, and Bernhard JD. Mastocytosis. Lancet 349:1379-1385, 1997.
2. Golden DB. Epidemiology of allergy to insect venoms and stings. Allergy Proc 10:103-107, 1989.
3. Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 52:259, 1973.
4. Reisman RE. Stinging insect allergy. Med Clin North Am 76:883-894, 1992.
5. Portnoy JM, Moffit JE, and Golden DB. Stinging insect hypersensitivity: a practice parameter. J Allergy Clin Immunol 103:963-980, 1999.
6. Light WC, Reisman RE, Shimizu M, et al. Unusual reactions following insect stings. J Allergy Clin Immunol 59:391, 1977.
7. Lichtenstein LM, and Golden DB. Postscript to bee stings: delayed "serum sickness." Hosp Pract 18:36, 1983.
8. Reisman RE, and Livingston A. Late-onset allergic reactions, including serum sickness, after insect stings. J Allergy Clin Immunol 84:331, 1989.
9. Poroshina I, Gushchin IS, Chitaeva VG, et al. A shock reaction from insect bites in patients with urticaria pigmentosa. Ter Arkh 67:33-35, 1995.
10. Castells MC, and Bingham C. Mastocytosis. Up to Date Electronic Database Online Version 11.1., 2002.
11. Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 96:25-45, 1991.
12. Metcalfe DD. Conclusions. Clinical advances in mastocytosis: an interdisciplinary roundtable discussion. J Invest Dermatol 96(supp):32S-39S, 1991.
13. Longley BJ, and Metcalfe DD. A proposed classification of mastocytosis incorporating molecular genetic. Hematol Oncol Clin North Am 14:697, 2000.
14. Longley BJ, Tyrell L, Lu S-Z, et al. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 12:312-315, 1996.
15. Sato-Matsumura KC, Matsumura T, Koizumi H, et al. Analysis of c-kit exon 11 and exon 17 of urticaria pigmentosa that occurred in monozygotic twin sisters. Br J Dermatol 140:1130-1132, 1999.
16. Offidani A, Cellini A, Simonetti O, and Bossi G. Urticaria pigmentosa in monozygotic twins. Arch Dermatol 130:935-936, 1994.
17. Boyano T, Carrascosa T, Val J, et al. Urticaria pigmentosa in monozygotic twins. Arch Dermatol 126:1375-1376, 1990.
18. Cainelli T, Marchesi L, Pasquali F, and Rozzoni M. Monozygtic twins discordant for cutaneous mastocytosis. Arch Dermatol 119:1021-1022, 1983.
19. Gay MW, Noojin RO, and Finley WH. Urticaria pigmentosa discordant in identical twins. Arch Dermatol 102:29-33, 1970.
20. Schwartz LB, Sakai K, Bradford TR, et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 96:2702-2710, 1995.
21. Garriga MM, Friedman MM, and Metcalfe DD. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol 82:425-432, 1988.
22. Golden DB, Valentine MD, Kagey-Sobotka A, and Lichtenstein LM. Regimens of Hymenoptera venom immunotherapy. Ann Intern Med 92:620-624, 1980.
23. Brehler R, Wolf H, Kutting B, et al. Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol 105:1231-1235, 2000.
24. Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1299:157-161, 1978.
25. Fricker M, Helbing A, Schwartz L, and Muller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol 100:11-15, 1997.
26. Oude-Elberink J, deMonchy J, Kors J, et al. Fatal anaphylaxis after a yellow jacket sting despite venom immunotherapy in two patients with mastocytosis. J Allergy Clin Immunol 99:153-154, 1997.
27. Golden DBK, Kwiterovitch KA, Addison BA, et al. Discontinuing venom immunotherapy: extended observations. J Allergy Clin Immunol 101:298-305, 1998.
28. Biedermann T, Rueff F, Sander CA, and Przybilla B. Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase. Br J Dermatol 41:1110-1112, 1999.
29. Bucher C, Simic P, Furrer J, and Wuthrich B. Mastocytosis: an important differential diagnosis in anaphylactoid reaction to Hymenoptera sting. A case report and overview of clinical aspects, diagnosis and current therapy of mastocytosis. Schweiz Rund Med Prax 89:411-418, 2000.
30. Kors JW, van Doormall JJ, and de Monchy JG. Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis. J Intern Med 233:255-258, 1993.